Ting Wu of Haiwen & Partners reviews the regulatory reforms taking place in China's life science and healthcare sector including legislation that has been released to encourage innovation and broaden market access to drugs, implementation of the patent linkage system, increasing antitrust enforcement pressure in the pharma sector, regulating medical devices, cosmetics and online hospitals.
Higher People's Court required to file review opinions with the Supreme People's Court
Disability compensation equality for urban and rural residents
Luka Groselj of Schellenberg Wittmer and Runyang Liu of Zhong Lun Law Firm provide practical guidance on contract drafting and performance to overcome possible non-signatory issues and how to navigate the current laws and court decisions when encountering such an issue
Luka Groselj of Schellenberg Wittmer and Runyang Liu of Zhong Lun Law Firm compare the legal principles and exceptions to the extension of arbitration agreements to non-signatories under Chinese and Swiss legal frameworks including succession, transfer, performance, guarantee, and subrogation and when the non-signatory may be bound by arbitration agreements
The draft establishes legal validity for online civil litigation
Beijing Municipality opens up IP-related arbitration to foreign institutions
Hong Kong Court grants landmark interlocutory injunctions in IP Case; Draft amendment to Anti-Monopoly Law targets platform economy; 4 G-SIBs to comply with new TLAC requirements By 2025
Criteria for determining willful infringement of intellectual property are specified
CNIPA differentiates patent and advertising violations
